Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
12 Jun 2017
Stereotactic Ablative Radiation Therapy: A Better Alternative to Conventional Therapy?
TREATMENT of metastatic kidney cancer using a focussed therapy known as stereotactic ablative radiation has been shown to result in >90% control of…
2
Mins
8 Jun 2017
The Importance of Civil Society Involvement in Eliminating Hepatitis C
This is an historic moment for hepatitis C treatment. With the advent of direct-acting antivirals (DAAs), we can now massively reduce the harm from an…
10
Mins
8 Jun 2017
A Discussion on the Management of Wilson Disease
Prof Peter Ferenci opened the meeting by providing a background to Wilson disease (WD), an enigmatic condition where no two cases are the same. He explored…
1
Mins
8 Jun 2017
Statins in Cirrhosis and Portal Hypertension
Statins have been used for almost three decades as cholesterol lowering drugs, yet additional effects…
2
Mins
8 Jun 2017
Magnetic Resonance Imaging of Diffuse Liver Diseases
Virtual liver biopsy (VLB) can be considered a multicomponent imaging biomarker able to provide fundamental information on the presence, distribution…
1
Mins
8 Jun 2017
Adenosine 2A Receptor Stimulation Prevents the Multiple Processes That Lead to Hepatic 'Immuno-Lipotoxicity' in Mice Fed a Methionine Choline-Deficient Diet and Blocks Non-Alcoholic Steatohepatitis Development
Non-alcoholic fatty liver disease (NAFLD) is a benign condition, but in ~20% of patients it can evolve into non-alcoholic steatohepatitis (NASH) with…
1
Mins
8 Jun 2017
A New Screening Strategy for Varices by Liver and Spleen Stiffness Measurements in Cirrhotic Patients: A Randomised Controlled Trial
Variceal screening with upper endoscopy is recommended in cirrhotic patients but unfortunately is costly, uncomfortable to patients, and has low uptake.
8
Mins
8 Jun 2017
Editor’s Pick: Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology
This review will cover the epidemiology, risk factors, pathogenesis, and pathology of hepatocellular carcinoma (HCC).
9
Mins
8 Jun 2017
Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis
Clinical presentation of hepatocellular carcinoma (HCC) can vary from asymptomatic patients to patients presenting variable symptoms such as pain, lethargy…
2
Mins
8 Jun 2017
Predicting Severe Liver Disease in the General Population: Abdominal Obesity, Insulin Resistance, Diabetes, Cholesterol, and Alcohol
Liver disease is the 13th leading cause of death worldwide, and hepatocellular carcinoma is the 2nd leading cause of cancer death. Finland has one of the…
←
1
2
3
…
140
141
142
143
144
145
146
…
192
193
194
→
We’ve noticed you’re accessing
from
North/South America.
View
View